TOPSPIN Study by the Centre for Chronic Disease Control (CCDC) Finds Two-drug Combination Therapies Effective in Improving Blood Pressure Control in Indians
A doctor checking the blood pressure of a patient
South-Asians represent one-fourth of the world population, and India alone constitutes one-sixth of the global population. Hypertension is a public health crisis affecting over one billion adults worldwide, including over 300 million living in India. Innovative solutions are needed to curb the growing tide of high blood pressure, which is the single highest risk factor for global deaths, and which requires effective management solutions. Current guidelines widely recommend initiating treatment with two-drug combinations, preferably in a single-pill formulation, to enhance blood pressure control. However, the suitability of these combinations for the South-Asian population remains unknown, as there are no studies in this regard.
The key takeaways are that all three combinations were equally effective in reducing blood pressure and were safe for patients.
What did the TOPSPIN study find
Blood pressure dropped significantly after 6 months, by around 14/8 mmHg when measured over 24 hours and about 30/14 mmHg in clinic settings.
Nearly 70% of patients reached the recommended blood pressure target below 140/90 mmHg , five times higher than India's current average control rate.
The pills were well-tolerated, with less than 3% of patients reporting side effects serious enough to stop treatment.
â
What do the Study leaders say
'This study shows that a single daily pill with two drugs can be a simple and powerful way to manage blood pressure in Indian and South Asian patients,' said Prof. Dorairaj Prabhakaran, Executive Director of CCDC and one of the study's lead authors. 'These findings can help guide doctors and policymakers. If added to India's list of essential medicines and made available at primary health centres, these pills could greatly improve blood pressure control in the country.'
Prof. Ambuj Roy, Professor of Cardiology at AIIMS Delhi, added, 'Nearly 70% of patients got their blood pressure under control, a huge improvement over the current national average. And the pills were safe and easy to use. This study gives clear guidance for better hypertension care.'
Prof. Neil Poulter, Professor at Imperial College London, emphasized the importance of studying how medicines work in different populations. 'Just as earlier research in Africa showed different results, this study gives strong evidence on what works best in South Asians.'
â
The TOPSPIN study results could help improve treatment not only in India, but also for South Asians living around the world.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
Doctor says this simple blood test could help identify heart attack risk in advance
One of India's foremost killers strikes without forewarning. The untimely heart attack takes the lives of many without presenting any unmistakable symptoms in the wake of medical developments. But what if there were a simple blood test that could warn of a heart attack years before it would take place? The recent advances in cardiovascular diagnostics are trying to fulfil this dream. The power of predictive biomarkers 'Scientists', as Dumont et al. have demonstrated, 'have found certain proteins and enzymes and inflammatory markers in blood which, if they appeared in higher than normal concentration, indicated that the person was at risk of cardiovascular disease long before any clinical presentation.' High-sensitivity C-reactive protein (hs-CRP) is one such marker. It signifies inflammation in the vessels of the heart-a silent trigger in most heart attacks. A protein blood test (genetic lipo/protein analysis) can predict heart attack risk by detecting elevated lipoprotein(a) levels linked to inherited cardiovascular disease. Troponin comes next on this list of probable biomarkers. Troponin is primarily used to identify heart attacks. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Wildlife Cameras Capture What No One Should See Ohi Blog Undo by Taboola by Taboola When troponin levels are elevated only a small amount, it has called to attention heart muscle stress or damage in the form of an early warning, years before. The other factor that has risen into prominence as a strong factor for early onset heart disease, especially in South Asians, is lipoprotein(a), or Lp(a), a genetic form of cholesterol. An unprecedented prospect for cardiovascular health In India, where CVDs affect younger populations, it is very much important to go in for early intervention. With urban lifestyles, increasing sedentarism, and the rising stress level, the younger lot itself is under threat. But for most routine checks, no one does anything else beyond reading cholesterol and blood pressure. With a little bit more of a proactive approach involving cardiac biomarkers testing, risk individuals could be identified earlier, so that they could then eliminate risk through lifestyle modification, early treatment with medication, or further diagnostic evaluation if warranted. This testing can be simple, non-fasting blood tests , no guruji, no stress test, no invasive procedure. Technology meets precision medicine The AI biomarker data integration is giving the jewel more shine. Advanced AI modeling techniques can now analyze the patient profile, which could include blood test results, genetic data, and lifestyle risk factors, and arrive at an individualized estimate of one's 10-year or even lifetime risk of developing heart disease. This individualized prediction and risk stratification allows for targeted prevention, rather than generic public-health-based preventions. A wake-up call for routine screening Despite these breakthroughs, public awareness and access remain barriers. Don't wait and wait until you suddenly have a heart attack and need an operation. We must shift our mindset from 'reactive treatment' to 'proactive prevention.' Including advanced cardiac biomarkers in annual health checks could be the key to reducing India's heart attack toll. Heart attacks don't just happen overnight, the silent damage increases over years. A basic blood check, administered at the right time, might provide a life-saving early alert. While science is arming us with tools, it's up to us as individuals, as doctors, as policymakers to act now before it's too late. Sameer Bhati Public Health Expert
Time of India
2 days ago
- Time of India
Instant scholar: From rock star to astrophysicist, Brian May's celestial pursuit of interplanetary dust
Representative image In the world of rock music, Brian May is celebrated as the iconic guitarist of Queen , a band that redefined the musical landscape of the 1970s and 80s. With his homemade 'Red Special' guitar and genre-defining solos in hits like Bohemian Rhapsody, We Will Rock You, and I Want It All, May carved his name into rock legend. But behind the stage lights and amplifiers, another passion flickered—one rooted not in music, but in the mysteries of the cosmos. This lesser-known chapter of Brian May's life came full circle in 2007, when he completed a long-delayed PhD in astrophysics, nearly four decades after beginning it. Titled "A Survey of Radial Velocities in the Zodiacal Dust Cloud", May's doctoral thesis is a blend of meticulous observational astrophysics and theoretical analysis, focusing on the interplanetary dust that forms the Zodiacal Cloud—a faint, diffuse band of light visible in the night sky under ideal conditions. This dust, remnants of comets and asteroid collisions, orbits the Sun and plays a crucial role in our understanding of the solar system's formation and dynamics. A Thesis Interrupted by Stardom Brian May first began work on his PhD at Imperial College London in the early 1970s. A physics and mathematics graduate, he was fascinated by solar system phenomena. Under the supervision of renowned astronomer Jim Ring, May embarked on an ambitious observational programme to measure the Doppler shifts in the light scattered by dust particles in the zodiacal cloud. His goal: to determine the radial velocities—essentially, the speed and direction of motion—of these dust particles relative to Earth. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like When Knee Pain Hits, Start Eating These Foods, and Feel Your Pain Go Away (It's Genius) Click Here However, May's academic journey was soon interrupted. Queen's rise to stardom was meteoric, and the demands of touring, recording, and public life meant his research took a back seat. For over 30 years, the project was left incomplete, but it remained on his mind. 'I never gave up hope that one day I would return to it,' he said in interviews. In 2006, with encouragement from former collaborators and Imperial College faculty, he dusted off his old notes, updated the literature review to reflect decades of advances, and resumed his research. The Science Behind the Stardust The zodiacal cloud is composed of countless micron-sized dust particles that orbit the Sun in the plane of the ecliptic. This dust reflects sunlight, producing a faint glow known as zodiacal light, most easily seen just before sunrise or after sunset in areas with minimal light pollution. Though ethereal in appearance, the dust has significant scientific relevance. Its dynamics help scientists understand the processes that shaped the early solar system, and its interaction with planetary bodies and solar radiation continues to influence space weather. Brian May's approach to studying this dust was through spectroscopic analysis—specifically, by examining the Doppler shifts in the Mg I (magnesium) absorption line at 5183.6 angstroms in the scattered sunlight. This shift provides information about the velocity of the scattering dust particles along the line of sight. If a particle moves toward Earth, the absorption line shifts slightly toward the blue end of the spectrum; if it moves away, the line shifts toward the red. To collect the necessary data, May constructed and deployed a pressure-scanned Fabry–Pérot interferometer—a highly precise optical instrument designed to measure very small wavelength shifts in light. Observations were conducted at the Teide Observatory on Tenerife in the Canary Islands, where the high altitude and clear skies made it an ideal location. Over two extended observing sessions in 1971 and 1972, May gathered more than 250 Fabry–Pérot scans of the zodiacal light from various points along the ecliptic. These spectra were later digitized and analysed for shifts in the Mg I line, allowing the determination of radial velocities of the dust in different parts of the sky. Findings and Implications May's results showed that the dust particles in the zodiacal cloud do not move in a purely circular fashion. Rather, their motion exhibited asymmetries that suggest a mixture of orbital inclinations and eccentricities. In particular, he found evidence for a retrograde component—a subset of particles moving in the opposite direction to the planets' orbits—as well as signs of interstellar dust inflow, consistent with theories that our solar system continuously sweeps up material from the interstellar medium. His measurements also supported a Keplerian motion model, wherein the dust follows elliptical orbits governed by the Sun's gravity, but also pointed to the influence of Poynting–Robertson drag—a process by which dust spirals slowly toward the Sun due to the combined effect of solar radiation pressure and the particles' own orbital motion. In the broader context of planetary science, May's work adds observational depth to the understanding of how dust evolves within the solar system. These insights are vital for calibrating space instruments, planning interplanetary missions, and understanding the debris environment through which spacecraft travel. A Thesis Completed—and a Scientist Reborn In 2007, May successfully defended his thesis and was awarded a PhD by Imperial College London, more than 36 years after beginning the work. The completed dissertation included a new literature review covering the intervening decades of research on interplanetary dust, updated data analysis methods, and critical comparisons with satellite missions like IRAS (Infrared Astronomical Satellite) and Helios, which provided additional context and validation. The completion of the thesis also marked May's full-circle return to science. He co-authored the popular science book Bang! – The Complete History of the Universe with astronomer Sir Patrick Moore and astrophysicist Chris Lintott, and later became Chancellor of Liverpool John Moores University. His blend of music and science has inspired students and fans alike, showcasing that intellectual curiosity knows no genre. Reflections on Dual Legacies Brian May's doctoral thesis is more than a scientific contribution—it is a testament to perseverance, intellectual ambition, and the bridging of two seemingly disparate worlds. In a sense, May represents the rare individual who refused to choose between his passions and instead found harmony between them. 'I'm a scientist at heart,' May has said. 'Music is my emotional outlet, but science is my way of understanding the universe.' Through 'A Survey of Radial Velocities in the Zodiacal Dust Cloud', May has made a meaningful mark in the field of astrophysics, proving that rock stars can reach for the stars in more ways than one. Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
Hans India
5 days ago
- Hans India
AIIMS-led study shows two-medicine combination therapy effective in controlling high BP
Using a single pill comprising two blood pressure medicines is a safe and highly effective way to treat hypertension among South Asians, particularly Indians, finds a study led by the All India Institute of Medical Sciences (AIIMS), New Delhi. The study, in partnership with the Centre for Chronic Disease Control (CCDC) and Imperial College London, UK, compared three widely used drug combinations: amlodipine plus perindopril, amlodipine plus indapamide, and perindopril plus indapamide. The first randomised trial to test three different two-drug combination pills among South Asians involved over 1,200 patients with uncontrolled hypertension across 32 hospitals in India. 'All three combinations worked equally well in reducing blood pressure and were safe for patients,' revealed the study, published in the journal Nature Medicine. The findings showed that either of the two-drug combinations led to a significant drop in blood pressure after 6 months -- by around 14/8 mmHg when measured over 24 hours and about 30/14 mmHg in clinic settings. 'Nearly 70 per cent of patients got their blood pressure under control, a huge improvement over the current national average. And the pills were safe and easy to use. This study gives clear guidance for better hypertension care,' said Dr Ambuj Roy, Professor of Cardiology at AIIMS Delhi. 'This study shows that a single daily pill with two drugs can be a simple and powerful way to manage blood pressure in Indian and South Asian patients,' said Dr Dorairaj Prabhakaran, Executive Director of CCDC. High blood pressure (hypertension) is the leading risk factor for death worldwide and affects over 300 million people in India alone. Treating it early and effectively can prevent heart attacks, strokes, and kidney failure. Doctors often recommend starting with two medications in one pill to control blood pressure better and help patients stick to treatment. But until now, no large study had tested which combinations worked best for South Asians, who make up a quarter of the world's population. The results revealed that nearly 70 per cent of patients with any of the dual drug therapy reached the recommended blood pressure target of below 140/90 mmHg -- five times higher than India's current average control rate. Less than 3 per cent of patients reported side effects serious enough to stop treatment. 'These findings can help guide doctors and policymakers. If added to India's list of essential medicines and made available at primary health centres, these pills could greatly improve blood pressure control in the country,' Prabhakaran said.
